MORGAN STANLEY - G1 THERAPEUTICS INC ownership

G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 113 filers reported holding G1 THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.83 and the average weighting 0.0%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of G1 THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$50,606
-86.2%
35,143
-76.2%
0.00%
Q2 2023$367,025
-47.9%
147,400
-44.0%
0.00%
Q1 2023$705,008
-65.0%
263,063
-29.0%
0.00%
Q4 2022$2,012,755
-52.4%
370,673
+9.6%
0.00%
-100.0%
Q3 2022$4,225,000
+367.9%
338,294
+85.2%
0.00%
Q2 2022$903,000
-56.8%
182,651
-33.6%
0.00%
Q1 2022$2,090,000
-43.4%
274,958
-24.0%
0.00%
Q4 2021$3,694,000
-20.5%
361,818
+4.4%
0.00%
-100.0%
Q3 2021$4,649,000
-63.0%
346,414
-39.4%
0.00%
-50.0%
Q2 2021$12,551,000
+120.6%
572,061
+142.0%
0.00%
+100.0%
Q1 2021$5,689,000
+35.0%
236,426
+0.9%
0.00%0.0%
Q4 2020$4,213,000
+159.9%
234,220
+66.9%
0.00%
Q3 2020$1,621,000
+55.6%
140,352
+226.4%
0.00%
Q2 2020$1,042,000
-37.9%
42,998
-71.8%
0.00%
Q1 2020$1,678,000
-9.1%
152,381
+118.2%
0.00%
Q4 2019$1,845,000
-49.7%
69,834
-56.6%
0.00%
-100.0%
Q3 2019$3,666,000
+752.6%
160,940
+1047.6%
0.00%
Q2 2019$430,000
-92.7%
14,024
-96.1%
0.00%
-100.0%
Q1 2019$5,906,000
+49.5%
355,742
+72.5%
0.00%
+100.0%
Q4 2018$3,950,000
+105.5%
206,244
+461.1%
0.00%
Q3 2018$1,922,000
+0.8%
36,756
-16.2%
0.00%
-100.0%
Q2 2018$1,907,000
+68.0%
43,872
+43.2%
0.00%
Q1 2018$1,135,000
+255.8%
30,640
+90.4%
0.00%
Q4 2017$319,000
+27.6%
16,089
+59.9%
0.00%
Q3 2017$250,000
+681.2%
10,062
+453.5%
0.00%
Q2 2017$32,0001,8180.00%
Other shareholders
G1 THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Birchview Capital, LP 120,000$172,8000.15%
DENALI ADVISORS LLC 148,800$214,2720.08%
XTX Topco Ltd 296,601$427,1050.07%
NEEDHAM INVESTMENT MANAGEMENT LLC 234,000$336,9600.06%
LEVEL FOUR ADVISORY SERVICES, LLC 183,400$264,0960.02%
Curi Wealth Management, LLC 70,742$101,8690.02%
FRANKLIN STREET ADVISORS INC /NC 83,400$1200.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 140,000$201,6000.01%
JACOBS LEVY EQUITY MANAGEMENT, INC 573,256$825,4890.01%
ALGERT GLOBAL LLC 68,100$980.01%
View complete list of G1 THERAPEUTICS INC shareholders